Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in <i>Staphylococcus aureus</i> bacteraemia: pooled analysis of two randomised trials.

In this subgroup, adjunctive fosfomycin was associated with significantly higher treatment success and a lower 60-day mortality compared with monotherapy, although this mortality difference did not reach statistical significance.

also in 111,027 other papers